Premaston

Quick links to important sections

Premaston

Method of action: Progestogen

Treatment option: Miscarriage

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Premaston

Property Description
Active ingredient Allylestrenol (Allyloestrenol)
Form Oral Tablet
Pharmacological class Synthetic Progestogen (Progestin)
Common use Hormonal support in pregnancy
Origin Synthetic (19-nortestosterone derivative)

What Type of Medicine is Premaston (Allylestrenol)?

Premaston is a pharmaceutical product containing the active ingredient Allylestrenol, which is classified as a synthetic progestogen, belonging to the high-level class of progestins. This orally active substance is a synthetic steroid molecule engineered to replicate the primary actions of the naturally occurring hormone progesterone. Allylestrenol is clinically recognized for its specific progestational activity, which acts as an agonist of the progesterone receptor (PR), a mechanism essential for promoting healthy biological conditions during gestation.

Composition, Origin, and Form: Allylestrenol Tablets

Allylestrenol is structurally defined as a 19-nortestosterone derivative that is entirely of synthetic origin. This specific chemical structure was developed to ensure effective systemic delivery when administered orally, providing a differentiating factor from many natural progesterone formulations that require alternative delivery methods. The medication is presented as a single-ingredient product exclusively in the form of an oral tablet. Allylestrenol has been noted for showing comparable outcomes to progesterone in improving delivery rates for women with threatened abortion, establishing its role as a convenient oral progestin option.

What is the General Purpose of This Progestogen?

The general purpose of this progestogen is to provide hormonal support to the reproductive system. By delivering the necessary progestational activity, Premaston promotes uterine environment stabilization, which includes supporting the uterine lining and fostering the relaxation of the uterine muscle. This specific physiological role assists the body in maintaining the necessary conditions for a secure state during the critical phases of gestation.

What side effects are possible with Premaston?

Possible Side Effects and Safety Information

The official safety information for Premaston (Allylestrenol) is categorized by regulatory agencies based on System-Organ Classes and frequency classifications to define its risk profile. This profile is strictly defined by documented adverse reactions and use restrictions.


Adverse Reactions and Frequencies

Adverse reactions associated with Allylestrenol are classified into frequency tiers in regulatory documents. Non-serious effects are typically documented in the Uncommon or Rare categories.

  • Uncommon Adverse Reactions: These commonly involve Gastrointestinal Disorders (such as Nausea and Vomiting) and Nervous System Disorders (such as Headache). Skin reactions, including Skin rash and Pruritus (itching), are also listed in this classification.
  • Rare Adverse Reactions: Less frequently reported effects include Dizziness and Oedema (fluid retention).

Serious Safety Constraints

Official regulatory documentation identifies conditions that strictly limit the use of this medicine. Premaston is contraindicated (should not be used) in patients with severe Liver Disease or the presence of Liver Tumors due to the potential for severe hepatic function disturbances. Its use is also restricted in the presence of undiagnosed vaginal bleeding and known Hypersensitivity to the active substance.

As a progestogen, the potential for serious events, such as Thromboembolic events, is noted in the overall safety profile, although the frequency with this specific compound is generally low. These constraints formally establish the boundaries for the acceptable use of this medicine.

Overdose and Emergency Response

Overdose and When to Seek Help

The official prescribing information for Premaston (Allylestrenol) strictly defines the recognized signs of overdose and the required emergency actions based on regulatory summaries. This section is limited to documented manifestations and regulator-mandated help-seeking triggers.

Documented Manifestations and Severe Outcomes

Overdose presentations involve effects on the central nervous system (CNS) and the cardiovascular system, requiring specific attention as defined by official labeling.

System Affected Documented Manifestations
CNS Effects Unusual drowsiness, seizures, loss of consciousness
Motor Effects Unusual muscle movement or rigidity of the face, neck, or limbs
Systemic/CV Effects Rapid pulse (Tachycardia), fainting (Syncope)

Severe outcomes explicitly noted in regulatory documents include seizures and loss of consciousness.

Regulatory Mandates for Emergency Response

The regulatory profile strictly mandates immediate action when an overdose is suspected or if severe manifestations occur.

  • Urgent Care Required: Seek immediate emergency medical treatment if any severe symptom of overdose is observed. Urgent medical assistance is required when manifestations such as seizures or loss of consciousness are suspected, given their classification as severe outcomes.
  • Acute Ingestion: Consultation with a medical professional is necessary following the acute ingestion of a quantity beyond the prescribed dose.
  • Management: Treatment for overdose is managed solely as symptomatic and supportive. No specific antidote is documented or known for Allylestrenol overdose, as stated in the prescribing information.

Therapeutic Uses of Premaston

What Premaston Treats: Main Uses and Benefits

Allylestrenol is commonly used across conditions presenting with acute episodes, recurrent manifestations, and in clinical settings where supportive symptom management is appropriate. The compound is relevant in clinical settings that involve symptoms associated with acute or episodic changes during gestation.

It is relevant for managing symptoms that interfere with daily comfort, such as physical discomfort like vaginal bleeding or painful uterine cramping. This supportive relief contributes to easing the overall symptom load and discomfort associated with a threatened episode.

Allylestrenol may be included in symptomatic management. It is used in areas where short-term symptom management is appropriate, including instances of recurrent pregnancy loss and following Assisted Reproductive Techniques (ART).

It may assist with maintaining functional stability during symptomatic phases when symptoms become more noticeable. It is relevant in situations where symptoms may intensify temporarily, providing support that helps ease the overall symptom burden.

Condition Frame: Relevant for
Uterine Cramping
Recurrent Miscarriage Support

Eligibility and Restrictions for Use

Official Eligibility Profile for Premaston (Allylestrenol)

The use of Premaston is strictly governed by regulatory documentation defining which populations are permitted, restricted, or prohibited from using the medicine.

Eligibility Classification Status According to Regulatory Label
Allowed Population Adult women of childbearing age for hormonal support during gestation.
Contraindicated Populations Patients with known hypersensitivity to Allylestrenol; Severe liver disease or liver tumours; Hormone-dependent malignant tumours; History of thromboembolic disorders; Undiagnosed abnormal vaginal bleeding.
Restricted/Conditional Use Patients with pre-existing renal disease; History of migraines, epilepsy, or depression.

Age and Physiological State Rules

Premaston is not recommended for use in the pediatric population (under 16 years) as safety and efficacy are not established. Use is also not established in the geriatric population. While the medicine is permitted and indicated during pregnancy, it is officially not recommended for women who are breastfeeding/lactating.

Connection to the overall eligibility profile

The regulatory label defines eligibility by limiting use to the reproductive phase and explicitly prohibiting treatment based on key comorbidities, organ function (hepatic), and hypersensitivity to ensure controlled patient access.

What should I know about interactions with other medicines?

Premaston, which contains the progestin allylestrenol, has the potential to interact with other medications, particularly those that influence the body’s metabolism of hormones. Pharmacokinetic interactions primarily involve changes in how the liver processes the drug.

Potential Interacting Drug Categories

Allylestrenol is metabolized by certain liver enzyme systems. Medications that either increase (induce) or decrease (inhibit) the activity of these enzymes may alter the concentration of allylestrenol in the bloodstream, potentially affecting its efficacy. Specific drug categories that may lead to clinically significant interactions include:

  • Enzyme Inducers: Certain antiepileptic drugs (AEDs) such as carbamazepine, phenytoin, phenobarbital, and primidone are known to induce various cytochrome P450 (CYP) and glucuronyl transferase (GT) enzymes. Concomitant use with such enzyme-inducing agents may lead to a reduction in the serum concentration of allylestrenol.
  • Anticoagulants: Allylestrenol may potentially decrease the anticoagulant effects of certain blood-thinning medications, necessitating careful monitoring of coagulation parameters when these drugs are used together.
Mechanism Interacting Agent Type Potential Effect
Enzyme Induction Certain Antiepileptics (e.g., Carbamazepine) Decreased plasma level of allylestrenol.
Pharmacodynamic Anticoagulants Potential reduction in anticoagulant activity.

Patients should inform a healthcare professional of all prescription and non-prescription products, including herbal remedies, they are currently taking. This allows for an assessment of potential interactions and necessary adjustments.

Mechanism of Action

Premaston acts as a synthetic progestogen, primarily targeting and functioning as an agonist at the Progesterone Receptor (PR), which is expressed in target tissues including the uterus, cervix, ovaries, hypothalamus, and mammary glands. Following cellular uptake, Premaston binds to the intracellular PR, initiating transcription of specific progesterone-responsive genes.

In the myometrium, activation of the PR leads to a downstream cascade that modulates smooth muscle activity by decreasing myometrial sensitivity to contractile agents such as oxytocin. This reduction in myometrial contractility is a key intracellular consequence. System-level physiological modulation involves changes in the reproductive tract, including endometrial transformation from a proliferative to a secretory state. Furthermore, this PR agonism modifies neuroendocrine function by suppressing the frequency of hypothalamic gonadotropin-releasing hormone ( GnRH) release, thereby blunting the pre-ovulatory luteinizing hormone ( LH) surge.

Dosage and Administration Information

Premaston is an orally administered medication containing Allylestrenol, supplied exclusively as a 5 mg tablet. Adherence to the medication’s labeled use is structured by distinct protocols tailored to the clinical scenario, distinguishing between short-term acute management and prolonged supportive care. The general principle of administration is the oral route. The tablet may be taken with or without food, but official instructions emphasize the importance of maintaining a consistent time of day for daily intake.

Dosage and frequency vary significantly according to the treatment phase. For scenarios requiring acute stabilization, such as threatened abortion, the standard regimen involves a higher dose of 5 mg three times daily (15 mg per day). This regimen is typically a short course, often maintained for five to seven days, or until the acute phase is stabilized. Following the resolution of acute symptoms, the instructions mandate that the daily dose must be gradually reduced over time.

In contrast, long-term supportive use, such as the protocol for recurrent conditions, typically involves a lower maintenance range of 5 mg to 10 mg daily, usually taken once or twice per day. This supportive therapy is a prolonged regimen that may continue until at least one month after the critical period of pregnancy. If a dose is missed, it should be taken when remembered, but compensation by taking a double dose is instructed against. The prescribing information also notes that the medication is not generally recommended for use in children under the age of 16 years.

Recent Clinical Evidence

Premaston: Recent Clinical Evidence

Clinical research on the active compound in Premaston (allylestrenol) has focused on its role as a progestogen, exploring its use primarily in the support of pregnancy outcomes. Trials evaluate whether administration of the compound influences outcomes related to threatened and recurrent miscarriage.


Phase 3 Clinical Trial Findings

Randomized controlled trials (RCTs) involving adult female participants have evaluated whether the drug influenced symptoms in women with specific high-risk pregnancy factors. Key study documentation includes:

  • Primary Focus: Studies reported findings related to key clinical measures, primarily focusing on pregnancy progression and live birth rates, and explored the findings regarding early symptoms of potential complications.
  • Safety Data: Adverse event rates were observed across study populations. The most commonly reported adverse events in the studies included mild nausea and headache. Study investigators documented findings related to discontinuation and recommended further research on specialist involvement.

Combination Therapy and Future Research

Research has also explored the study drug when administered with other studied treatments that support early pregnancy. This evaluation was often explored for differences in outcomes when compared to monotherapy (single-drug treatment). While early results from preliminary trials evaluated whether there were differences in reported response rates, the evidence remains limited and is not considered conclusive.

Ongoing Phase 3 trials are currently recruiting to more definitively evaluate the comparison of combination therapy versus monotherapy to better understand all possible research findings.

Frequently Asked Questions (FAQ)

Common questions about Premaston (FAQ)


Q: Why is it important to know about Premaston's interactions with other drugs?

Knowing about potential drug interactions is important because other medicines can affect how the body processes Premaston (Allylestrenol). Medications that speed up or slow down the liver’s handling of the drug could change its concentration in the bloodstream. This alteration might affect the expected level of support the medicine provides.


Q: What does the term 'contraindication' mean for Premaston?

A contraindication is a term used in official medical information to identify a specific situation or pre-existing health condition in which a medicine should not be used. Taking the medicine under a contraindication could potentially be harmful. For Premaston, examples include severe liver disease and known hypersensitivity to the active substance.


Q: Why is Premaston taken for the condition it treats?

Premaston is prescribed to provide hormonal support because its active ingredient acts as a progestogen, similar to the naturally occurring hormone progesterone. By doing this, it works to relax the muscles of the uterus and supports the uterine lining. This physiological role assists the body in maintaining stable conditions during certain phases of gestation.


Q: Is Premaston a scheduled or controlled substance?

Regulatory databases classify Premaston (Allylestrenol) as a synthetic steroid and progestogen based on its therapeutic class. The available regulatory documentation does not generally list the drug as a controlled substance in the jurisdictions where it is commonly prescribed.


Q: How quickly should I expect to see the effects of Premaston, based on studies?

The specific time it takes for a person to feel the full therapeutic effect (onset of action) is not explicitly detailed in the official product information. However, studies show that the active compound is processed and cleared from the body with a relatively short elimination half-life, typically lasting from several hours up to a day.


Q: Do food or certain types of drinks interact with Premaston?

Official instructions state the medicine can be taken with or without food. Specific interactions with common food items or drinks are not typically listed in the drug's interaction section, which primarily focuses on interactions with other medicines.


Q: Is it normal to feel a change in energy level when starting Premaston?

Changes in energy level and tiredness are among the reported side effects for Premaston (Allylestrenol) noted in official safety information.


Q: Is there information about using Premaston during pregnancy?

The medicine is designed and indicated for use during pregnancy to provide hormonal support. Studies have indicated that when prescribed during the first and second trimesters, well-controlled data revealed no risk to the fetus.


Q: What are the official recommendations regarding Premaston and breastfeeding?

Premaston is officially not recommended for use by women who are breastfeeding or lactating. The rationale is that the active ingredient may pass into breast milk, which could potentially affect the nursing infant.


Q: Can older adults typically use Premaston?

The medicine is primarily indicated for use during the reproductive phase of life. Regulatory information states that the safety and effectiveness have not been established in the geriatric population (older adults).


Q: Are there any known interactions between Premaston and common pain relievers?

Regulatory documents specifically list drug classes such as certain antiepileptics and anticoagulants as interacting agents. There is no specific official warning provided regarding an interaction with common, non-prescription pain relievers.


Q: Is there a link between Premaston and changes in mood?

Yes, changes in mood, including depression and mood swings, have been reported as potential side effects in official documents. The product information also advises caution for patients with a history of depression.


Q: Why do official documents mention monitoring specific lab tests while taking Premaston?

Official warnings and precautions cite restrictions based on the patient's existing organ function, particularly in cases of severe liver or kidney disease. This information suggests that routine clinical monitoring is sometimes conducted to observe stability related to the patient’s organ function.


Q: Does Premaston contain any ingredients that cause allergic reactions?

The official product information lists a known hypersensitivity (allergic reaction) to the active substance, Allylestrenol, as a contraindication. The safety profile does not generally itemize or detail allergic risks associated with the inactive ingredients used in the tablet formulation.


Q: Is there a patient information leaflet (PIL) available for Premaston online?

Patient Information Leaflets (PILs) or similar regulatory documents are standard requirements for prescription drugs. These official documents are generally made available online via the governmental drug agencies in the countries where the medicine is approved.


Q: Do clinical trials support the use of Premaston for its approved indication?

Studies have indicated that Premaston (Allylestrenol) is explored as an effective option for its approved uses. Research has evaluated the drug's influence on outcomes for women with specific high-risk pregnancy factors, supporting its role in providing hormonal support.


Q: Are there restrictions on consuming alcohol while using Premaston?

There is no specific contraindication listed for alcohol consumption in the official prescribing information. However, some foreign safety advice recommends consulting a healthcare provider, as there is limited scientific data on the interaction between this specific drug and alcohol.


Q: What are the most serious side effects listed in regulatory documents for Premaston?

Serious adverse events to monitor for include signs of thromboembolic events (blood clots, such as sudden chest pain or swelling in the legs). Other serious concerns listed are severe abdominal pain and yellowing of the skin or eyes, which can be signs of liver dysfunction.


Q: Does Premaston interact with herbal supplements?

Yes, the prescribing information advises that patients inform their healthcare provider of all non-prescription products, including herbal remedies. This is because some herbal supplements may contain ingredients that can affect the body's processing of Premaston.


Q: Is Premaston considered a 'maintenance' drug or a short-term treatment?

The regulatory protocols indicate that Premaston is used for both. Dosage instructions distinguish between short-term use, such as acute stabilization, and prolonged supportive care, which may continue as a longer maintenance regimen.


Q: Can Premaston cause changes in weight?

Yes, official safety documents list changes in body weight as a potential side effect of Premaston. Furthermore, fluid retention, or oedema, is also listed as a potential side effect that could contribute to weight changes.


Q: What population groups were included in the main Premaston research studies?

Main clinical trials involved adult female participants. These studies focused on women who had specific high-risk factors related to pregnancy and evaluated the drug's role in providing hormonal support.


Q: Is Premaston related chemically to any older medications?

Allylestrenol is classified chemically as a 19-nortestosterone derivative. This chemical classification is shared by other synthetic progestogens, but its specific structure and properties result in a distinct pharmacological profile compared to other related medications.


Q: Does taking Premaston require any routine check-ups?

The official label advises that routine check-ups, which may include procedures like ultrasound and blood hormone monitoring, may be conducted during treatment. This is relevant when managing high-risk factors or monitoring for potential effects on organ function.


Q: Why is Premaston not recommended for certain age groups?

Premaston is officially not recommended for the pediatric population (under 16 years) because the regulatory bodies have not established the safety and effectiveness of the medicine for children and teenagers.


Q: What is the potential impact of Premaston on kidney function?

The official label advises caution when the medicine is used in patients with pre-existing renal disease (kidney problems). This restriction is in place because the official label advises caution due to the risk of the underlying kidney condition worsening.


Q: Where can I find the official FDA or EMA document for Premaston?

The official prescribing information for Allylestrenol is available via the governmental drug agencies in the countries where it is approved. This includes the data sheets published by government health bodies in various jurisdictions.


Q: Do patients typically take Premaston alone or with other treatments?

Clinical research has explored the use of Premaston both as a monotherapy (taken alone) and in combination therapy with other treatments. The choice of approach depends on the individual clinical situation.


Q: Does Premaston have a black box warning?

A U.S. FDA Black Box Warning status cannot be confirmed for this product. This is because Allylestrenol is not currently approved with a U.S. FDA label.


Q: Does Premaston affect sleep patterns?

Yes, the official label reports that the medicine may cause sleepiness or drowsiness as a potential side effect. This is one of the effects listed under nervous system disorders.


Q: Is Premaston the same kind of drug as similar-sounding medicines?

Premaston is classified as a synthetic progestogen and is a 19-nortestosterone derivative, placing it in a category of similar hormones. However, its specific structure and properties result in a distinct pharmacological profile compared to other related medications.

How should Premaston be stored and disposed of?

Storage Conditions and Container Rules

Premaston (Allylestrenol) oral tablets must be stored according to regulatory requirements to ensure stability. The product should be maintained at room temperature, generally defined as below 30 C (86 F). The medication must be protected from light and moisture, which typically requires keeping the tablets in the original blister pack or container until use.

Child Safety and Disposal

Mandatory regulatory instructions require that the medication be stored out of the sight and reach of children to prevent accidental ingestion. Unused or expired tablets should be disposed of via a drug take-back program or mail-back option. If these are unavailable, official guidelines permit disposal in the household trash after mixing the tablets with an undesirable substance, such as coffee grounds or cat litter, and placing the mixture in a sealed container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Premaston found in:

A-Z Index: